Publication: MicroRNAs in T Cell-Immunotherapy.
| dc.contributor.author | Dosil, Sara G | |
| dc.contributor.author | Rodríguez-Galán, Ana | |
| dc.contributor.author | Sánchez-Madrid, Francisco | |
| dc.contributor.author | Fernández-Messina, Lola | |
| dc.contributor.funder | Ministerio de Economía y Competitividad (España) | es_ES |
| dc.contributor.funder | Comunidad de Madrid (España) | es_ES |
| dc.contributor.funder | Instituto de Salud Carlos III | es_ES |
| dc.contributor.funder | Fundación La Caixa | es_ES |
| dc.contributor.funder | Asociación Española Contra el Cáncer | es_ES |
| dc.contributor.funder | Ministerio de Ciencia, Innovación y Universidades (España) | es_ES |
| dc.contributor.funder | Fundación ProCNIC | es_ES |
| dc.contributor.funder | Ministerio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España) | es_ES |
| dc.date.accessioned | 2023-09-04T14:16:08Z | |
| dc.date.available | 2023-09-04T14:16:08Z | |
| dc.date.issued | 2022-12-23 | |
| dc.description.abstract | MicroRNAs (miRNAs) act as master regulators of gene expression in homeostasis and disease. Despite the rapidly growing body of evidence on the theranostic potential of restoring miRNA levels in pre-clinical models, the translation into clinics remains limited. Here, we review the current knowledge of miRNAs as T-cell targeting immunotherapeutic tools, and we offer an overview of the recent advances in miRNA delivery strategies, clinical trials and future perspectives in RNA interference technologies. | es_ES |
| dc.description.peerreviewed | Sí | es_ES |
| dc.description.sponsorship | This manuscript was funded by grants AEI/10.13039/501100011033, PID-2020-120412RBI100 and PDC2021-121797-I00 (F.S.-M.) from the Spanish Ministry of Economy and Competitiveness; CAM (S2017/BMD-3671-INFLAMUNE-CM) from the Comunidad de Madrid (F.S.-M.), CIBERCV (CB16/11/00272) and BIOIMID PIE13/041 from the Instituto de Salud Carlos “la Caixa” Foundation under the project code HR17-00016. The current research is supported by AECC-Coordinated Grant 2022 (PRYCO223002PEIN). The CNIC is supported by the Ministerio de Ciencia, Innovacion y Universidades and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015- 0505). IMDEA Nanociencia acknowledges support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D (MINECO, CEX2020-001039-S). S.G.D. is supported by a grant from the Spanish Ministry of Universities. | es_ES |
| dc.format.number | 1 | es_ES |
| dc.format.volume | 24 | es_ES |
| dc.identifier.citation | Int J Mol Sci. 2022 Dec 23;24(1):250. | es_ES |
| dc.identifier.doi | 10.3390/ijms24010250 | es_ES |
| dc.identifier.e-issn | 1422-0067 | es_ES |
| dc.identifier.journal | International journal of molecular sciences | es_ES |
| dc.identifier.pubmedID | 36613706 | es_ES |
| dc.identifier.uri | http://hdl.handle.net/20.500.12105/16401 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/AEI/10.13039/501100011033 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/PID-2020-120412RBI100 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/PDC2021-121797-I00 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/S2017/BMD-3671-INFLAMUNE-CM | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/CB16/11/00272 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/BIOIMID PIE13/041 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/HR17-00016 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/PRYCO223002PEIN | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/SEV-2015-0505 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/MINECO/CEX2020-001039-S | es_ES |
| dc.relation.publisherversion | 10.3390/ijms24010250 | es_ES |
| dc.repisalud.institucion | CNIC | es_ES |
| dc.repisalud.orgCNIC | CNIC::Grupos de investigación::Comunicación Intercelular en la Respuesta Inflamatoria | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Atribución 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.subject.mesh | MicroRNAs | es_ES |
| dc.subject.mesh | T-Lymphocytes | es_ES |
| dc.subject.mesh | RNA Interference | es_ES |
| dc.subject.mesh | Precision Medicine | es_ES |
| dc.subject.mesh | Immunotherapy | es_ES |
| dc.title | MicroRNAs in T Cell-Immunotherapy. | es_ES |
| dc.type | review | es_ES |
| dc.type.hasVersion | VoR | es_ES |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- MicroRNAs in T Cell-Immunotherapy_Int J Mol Sci_2022.pdf
- Size:
- 1.36 MB
- Format:
- Adobe Portable Document Format
- Description:


